secwatch / observer
8-K filed May 27, 2026, 4:20 PM ET ticker CATX CIK 0000728387
other confidence high sentiment neutral materiality 0.15

Perspective Therapeutics announces 2026 annual meeting voting results; all director nominees elected

Perspective Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Perspective Therapeutics, Inc. shareholders approved Advisory vote on frequency of advisory stockholder votes on executive compensation at the 2026-05-27 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
The stockholders of the Company voted, on a non-binding advisory basis, on how frequently future non-binding advisory votes on the compensation of the Company’s named executive officers should be held. The votes were cast as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 76,479,166 274,495 364,497 165,067 20,599,237
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Perspective Therapeutics, Inc. shareholders approved Ratification of appointment of WithumSmith+Brown, PC as independent registered public accounting firm at the 2026-05-27 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
The stockholders of the Company ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Perspective Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-27 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
The stockholders of the Company elected Lori A. Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III to the Company’s Board of Directors
View on SEC.gov

Browse all shareholder votes →

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-241940
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.